tradingkey.logo

Aclarion Inc

ACON
7.500USD
-0.330-4.21%
Cierre 11/04, 16:00ETCotizaciones retrasadas 15 min
4.37MCap. mercado
PérdidaP/E TTM

Más Datos de Aclarion Inc Compañía

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Información de Aclarion Inc

Símbolo de cotizaciónACON
Nombre de la empresaAclarion Inc
Fecha de salida a bolsaApr 22, 2022
Director ejecutivoMr. Brent Ness
Número de empleados6
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 22
Dirección8181 Arista Place
CiudadBROOMFIELD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80021
Teléfono18332752266
Sitio Webhttps://aclarion.com/
Símbolo de cotizaciónACON
Fecha de salida a bolsaApr 22, 2022
Director ejecutivoMr. Brent Ness

Ejecutivos de Aclarion Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--
Dr. Scott Breidbart, M.D.
Dr. Scott Breidbart, M.D.
Independent Director
Independent Director
--
--
Mr. David Neal
Mr. David Neal
Director
Director
--
--
Dr. Jeff Thramann, M.D.
Dr. Jeff Thramann, M.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brent Ness
Mr. Brent Ness
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.00
--
Mr. Ryan Bond
Mr. Ryan Bond
Chief Strategy Officer
Chief Strategy Officer
1.00
--
Mr. Gregory A. (Greg) Gould
Mr. Gregory A. (Greg) Gould
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Steve Deitsch
Mr. Steve Deitsch
Independent Director
Independent Director
--
--
Ms. Amanda Williams
Ms. Amanda Williams
Independent Director
Independent Director
--
--
Mr. William Wesemann
Mr. William Wesemann
Lead Independent Director
Lead Independent Director
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 23 de ago
Actualizado: sáb., 23 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Otro
98.32%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
1.05%
Geode Capital Management, L.L.C.
0.32%
UBS Financial Services, Inc.
0.30%
Tower Research Capital LLC
0.01%
Otro
98.32%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
1.35%
Investment Advisor/Hedge Fund
0.32%
Hedge Fund
0.01%
Otro
98.32%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
9
10.66K
1.68%
+7.30K
2025Q2
17
378.00
0.06%
-14.00
2025Q1
19
368.00
0.06%
+366.00
2024Q4
16
3.00
0.00%
-7.00
2024Q3
21
2.00
0.00%
-10.00
2024Q2
27
2.00
7.77%
-3.00
2024Q1
28
3.00
9.70%
--
2023Q4
35
1.00
14.29%
-1.00
2023Q3
34
1.00
25.00%
-1.00
2023Q2
33
1.00
25.00%
-1.00
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
1.71K
0.29%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
1.59K
0.27%
+610.00
+62.37%
Aug 31, 2025
UBS Financial Services, Inc.
1.73K
0.3%
+1.68K
+3225.00%
Jun 30, 2025
Tower Research Capital LLC
75.00
0.01%
+72.00
+2400.00%
Jun 30, 2025
Thramann (Jeffrey John)
10.00
0%
+10.00
--
May 09, 2025
BofA Global Research (US)
8.00
0%
+4.00
+100.00%
Jun 30, 2025
Clear Street LLC
3.00
0%
--
--
Jun 30, 2025
Ness (Brent)
3.00
0%
+3.00
--
May 09, 2025
Neal (David K)
2.00
0%
+2.00
--
May 09, 2025
Wesemann (William G)
1.00
0%
+1.00
--
May 09, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Fecha
Tipo
Relación
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Mar 26, 2025
Merger
27→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 24, 2025
Merger
335→1
Jan 02, 2024
Merger
16→1
Jan 02, 2024
Merger
16→1
Ver más
KeyAI